Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01069952 · ClinicalTrials.gov registry record · Phase 2
Electrical Stimulation of the Internal Capsule for Intractable Depression
A Phase 2 study of Depression, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01069952: Completed Phase 2 study of Depression, sponsored by Butler Hospital.
NCT01069952 is a Phase 2 study of Depression that has completed, run by Butler Hospital. The registered enrollment target is 5 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01069952, a Phase 2 study of Depression, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the safety and efficacy of deep brain stimulation in treating people with several and otherwise treatment-resistant depression.
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation System
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2002-12 |
| Phase | Phase 2 |
What the finished NCT01069952 record still lists
NCT01069952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation System is the first listed.
NCT01069952 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01069952 about?
NCT01069952 is a clinical study titled "Electrical Stimulation of the Internal Capsule for Intractable Depression". This study will evaluate the safety and efficacy of deep brain stimulation in treating people with several and otherwise treatment-resistant depression.
What is the current status of trial NCT01069952?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2002-12.
What conditions does trial NCT01069952 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT01069952?
The interventions under investigation include: Deep Brain Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT01069952?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01069952 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01069952's enrollment target sits among peer trials
5 674th of 679 higher than 5 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia